8W3R | pdb_00008w3r

Crystal structure of prefusion-stabilized RSV F protein UFCR2-iSS-P2-NQ in complex with A4 single-chain fragment variable


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 4.02 Å
  • R-Value Free: 
    0.303 (Depositor), 0.304 (DCC) 
  • R-Value Work: 
    0.249 (Depositor), 0.249 (DCC) 
  • R-Value Observed: 
    0.252 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 8W3R

Ligand Structure Quality Assessment 


This is version 1.0 of the entry. See complete history

Literature

Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus.

Lee, Y.Z.Han, J.Zhang, Y.N.Ward, G.Braz Gomes, K.Auclair, S.Stanfield, R.L.He, L.Wilson, I.A.Zhu, J.

(2024) Nat Commun 15: 9939-9939

  • DOI: https://doi.org/10.1038/s41467-024-54287-x
  • Primary Citation Related Structures: 
    8W3E, 8W3F, 8W3G, 8W3H, 8W3I, 8W3J, 8W3K, 8W3L, 8W3N, 8W3O, 8W3P, 8W3Q, 8W3R

  • PubMed Abstract: 

    Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) cause human respiratory diseases and are major targets for vaccine development. In this study, we design uncleaved prefusion-closed (UFC) trimers for the fusion protein (F) of both viruses by examining mutations critical to F metastability. For RSV, we assess four previous prefusion F designs, including the first and second generations of DS-Cav1, SC-TM, and 847A. We then identify key mutations that can maintain prefusion F in a native-like, closed trimeric form (up to 76%) without introducing any interprotomer disulfide bond. For hMPV, we develop a stable UFC trimer with a truncated F 2 -F 1 linkage and an interprotomer disulfide bond. Dozens of UFC constructs are characterized by negative-stain electron microscopy (nsEM), x-ray crystallography (11 RSV-F structures and one hMPV-F structure), and antigenic profiling. Using an optimized RSV-F UFC trimer as bait, we identify three potent RSV neutralizing antibodies (NAbs) from a phage-displayed human antibody library, with a public NAb lineage targeting sites Ø and V and two cross-pneumovirus NAbs recognizing site III. In mouse immunization, rationally designed RSV-F and hMPV-F UFC trimers induce robust antibody responses with high neutralizing titers. Our study provides a foundation for future prefusion F-based RSV and hMPV vaccine development.


  • Organizational Affiliation
    • Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.

Macromolecule Content 

  • Total Structure Weight: 84.2 kDa 
  • Atom Count: 5,218 
  • Modeled Residue Count: 681 
  • Deposited Residue Count: 779 
  • Unique protein chains: 2

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
A4 single-chain fragment variable272Homo sapiensMutation(s): 0 
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
prefusion-stabilized RSV F protein UFCR2-iSS-P2-NQB [auth F]507Homo sapiensMutation(s): 0 
UniProt
Find proteins for G3C7N1 (Human respiratory syncytial virus)
Explore G3C7N1 
Go to UniProtKB:  G3C7N1
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupG3C7N1
Glycosylation
Glycosylation Sites: 1
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
NAG

Query on NAG



Download:Ideal Coordinates CCD File
C [auth F]2-acetamido-2-deoxy-beta-D-glucopyranose
C8 H15 N O6
OVRNDRQMDRJTHS-FMDGEEDCSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 4.02 Å
  • R-Value Free:  0.303 (Depositor), 0.304 (DCC) 
  • R-Value Work:  0.249 (Depositor), 0.249 (DCC) 
  • R-Value Observed: 0.252 (Depositor) 
Space Group: H 3 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 100.24α = 90
b = 100.24β = 90
c = 588.218γ = 120
Software Package:
Software NamePurpose
PHENIXrefinement
HKL-2000data reduction
HKL-2000data scaling
PHENIXphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Other privateUnited States--

Revision History  (Full details and data files)

  • Version 1.0: 2025-01-15
    Type: Initial release